Mylan Reports - Industry Research

Reports Featuring Mylan

Carbonated Beverages Market Major Players

Benzodiazepine Drugs Market

The benzodiazepine drugs market studied was anticipated to grow with a CAGR of 2.4%, during the forecast period.

Primary Biliary Cholangitis (PBC) Therapeutics Market

The global primary biliary cholangitis (PBC) market is projected to grow with a CAGR of nearly 10% over the forecast period.

Cystic Fibrosis (CF) Therapeutics Market

The cystic fibrosis therapeutics market is anticipated to register a CAGR of nearly 9.1% during the forecast period.

Imatinib Drug Market

The Imatinib Drug Market is expected to register a CAGR of 3% during the forecast period.

The Capecitabine market studied was anticipated to grow with a CAGR of 5.5% during the forecast period owing to the rising demand for target drug therapy to decrease the possible side effects without affecting normal cells.

Sleep Disorders Treatment Market

The sleep disorders treatment market is anticipated to witness a CAGR of nearly 7.1% during the forecast period.

Global Fibrate Drugs Market

The fibrate drugs market is projected to register a CAGR of 5.2% during the forecast period.

Japan Drug Delivery Devices Market

The Japan Drug Delivery Devices Market is expected to register a CAGR of nearly 4.5% during the forecast period.

Basal Cell Carcinoma Treatment Market

The Basal Cell Carcinoma Treatment Market is expected to register a CAGR of 9.3% over the forecast period.

Global Hormonal Contraceptives Market

The hormonal contraceptives market is poised to grow at a CAGR of 4% over the forecast period.

Gemcitabine Hydrochloride Market

The Gemcitabine Hydrochloride Market is expected to register a CAGR of 7.1% during the forecast period.

Cytotoxic Drugs Market

The global cytotoxic drugs market size is expected to register a CAGR of 1.2% over the forecast period.

Sustained Release Excipients Market

The sustained release excipients market is anticipated to register a CAGR of 7.1% during the forecast period.

United States Heparin Market

The United States Heparin Market size is estimated at USD 1.33 billion in 2024, and is expected to reach USD 1.82 billion by 2029, growing at a CAGR of 6.54% during the forecast period (2024-2029).

Cardiac Arrhythmia Therapeutics Market

The Cardiac Arrhythmia Therapeutics Market is expected to register a CAGR of 4.3% during the forecast period.

Alexipharmic Drugs Market

The alexipharmic drugs market studied was anticipated to grow with a CAGR of 4.9% during the forecast period.

Hydroxychloroquine Drugs Market

The global hydroxychloroquine drugs market studied was anticipated to register a CAGR of nearly 16.8% during the forecast period.

Dacryocystitis Market

The dacryocystitis market studied is anticipated to register a CAGR of nearly 4.2%, during the forecast period.

North America Sulfonylureas Market

The North America Sulfonylureas Market size is estimated at USD 3.11 billion in 2024, and is expected to reach USD 3.41 billion by 2029, growing at a CAGR of 1.9% during the forecast period (2024-2029).